ABSTRACT

Objective:

The incidence of endometrial polyp is 16-34% within the whole population nonetheless increases after menopause. The incidence of cancer involvement through the endometrial polyp is 0.8-4.8%.

Material and Methods:

Study is designed as a retrospective descriptive study. Medical records of the patients which were diagnosed to have endometrial polyp within January 2009-January 2012 were reviewed. The patients which were diagnosed to have malignancy based on endometrial polyp were included.

Results:

325 patients were obtained to have endometrial polyp, and 11 of them (3.4%) were found to be appropriate for study. 140 patients (59%) were postmenopousal and 285 patients (41%) were premenopousal 67 (43%) of the postmenopausal patients had endometrial sampling due to thickened endometrium (10mm) although they were asymptomatic. 73 (57%) of the postmanopausal patients were symptomatic. Six of this postmenouposal patients (4.2%) had malignancy based on the endometrial polyp, all of this patients were in symtomatic group. 192 of the 325 patients (59%) were symptomatic and 10 of this patients (5.2%) had malignancy based on endometrial polyp. Only one patient was asymptomatic. Histopathologic type was endometrioid and except one patient who has stage 1B disease, all patients have stage 1A disease. Two patients’ carcinoma were limited to the polyp, endometrial tissue had no sign of malignancy.

Conclusion:

We conclude that endometrial biopsy should be performed at the patients known to have endometrial polyp after menopause and symptomatic patient, regardless the menopausal status. Eventhoug malign endometrial polyps are diagnosed at eraly stages, with the advanced age grade of the tumor increases.